Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
221.1 USD | -1.60% | -3.11% | -6.51% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.51% | 1.16TCr | |
+34.74% | 5.08TCr | |
+0.61% | 4.28TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.95TCr | |
+10.85% | 2.61TCr | |
-21.57% | 1.91TCr | |
+8.73% | 1.31TCr | |
+26.98% | 1.22TCr | |
+24.38% | 1.21TCr |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Wells Fargo Adjusts Charles River Laboratories International Price Target to $275 From $280, Maintains Overweight Rating